Molecular characterization of feline type I interferon receptor 2

Journal of Interferon and Cytokine Research

Volumn 30, Issue 2, 2010, Pages 81-88

  Xue, Qinghua ^a   Yang, Limin ^a   Liu, Xiaoling ^a   Liu, Wenjun ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; FIBRONECTIN; INTERFERON; INTERFERON RECEPTOR; INTERFERON RECEPTOR 2; MUTANT PROTEIN; OMEGA INTERFERON; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CAT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATS; CLONING, MOLECULAR; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

FELIDAE;

EID: 77649302116     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0031     Document Type: Article

References (35)

1. Arnold K, Bordoli L, Kopp J, Schwede T. 2006. The SWISS-MODEL workspace: a web-based environment for protein structure homology modeling. Bioinformatics 22(2):195-201.
2. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. 2004. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340(4):783-795.
3. Chill JH, Quadt SR, Levy R, Schreiber G, Anglister J. 2003. The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. Structure 11(7):791-802.
4. Chuntharapai A, Gibbs V, Lu J, Ow A, Marsters S, Ashkenazi A, De Vos A, Jin Kim K. 1999. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. J Immunol 163(2):766-773.
5. Cohen B, Novick D, Barak S, Rubinstein M. 1995. Ligand-induced association of the type I interferon receptor components. Mol Cell Biol 159(8):4208-4214.
6. de Mari K, Maynard L, Eun HM, Lebreux B. 2003. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled f eld trial. Vet Rec 152(4):105-108.
7. de Mari K, Maynard L, Sanquer A, Lebreux B, Eun HM. 2004. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodef ciency virus (FIV)-coinfected symptomatic cats. J Vet Intern Med 18(4):477-482.
8. Domanski P, Fish E, Nadeau OW, Witte M, Platanias LC, Yan H, Krolewski J, Pitha P, Colamonici OR. 1997 A region of the β sub-unit of the interferon α receptor different from Box 1 interacts with Jak1 and is suff cient to activate the Jak-Stat pathway and induce an antiviral state. J Biol Chem 272(42):26388-26393.
9. Flores I, Mariano TM, Pestka S. 1991. Human interferon omega (ω) binds to the α/β receptor. J Biol Chem 266(30):19875-19877
10. Foster GR, Masri SH, David R, Jones M, Datta A, Lombardi G, Runkell L, de Dios C, Sizing I, James MJ, Marelli-Berg FM. 2004. IFN-alpha subtypes differentially affect human T cell motility. J Immunol 173(3):1663-1670.
11. Guex N, Peitsch MC. 1997 SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18(15):2714-2723.
12. Jaitin DA, Roisman LC, Jaks E, Gavutis M, Piehler J, Van der Heyden J, Uzé G, Schreiber G. 2006. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced aff nity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol 26(5):1888-1897
13. Langer JA, Cutrone EC, Kotenko S. 2004. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 15(1):33-48.
14. Lewerenz M, Mogensen KE, Uzé G. 1998. Shared receptor components but distinct complexes for alpha and beta interferons. J Mol Biol 282(3):585-599.
15. Martin V, Najbar W, Gueguen S, Grousson D, Eun HM, Lebreux B, Aubert A. 2002. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 89(2-3):115-127
16. Minagawa T, Ishiwata K, Kajimoto T. 1999. Feline interferon-omega treatment on canine parvovirus infection. Vet Microbiol 69(1-2):51-53.
17. Nakamura N, Sudo T, Matsuda S, Yanai A. 1992. Molecular cloning of feline interferon cDNA by direct expression. Biosci Biotechnol Biochem 56(2):211-214.
18. Novick D, Cohen B, Rubinstein M. 1994. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77(3):391-400.
19. Piehler J, Schreiber G. 1999a. Biophysical analysis of the interaction of Human IFNAR2 expressed in E. coli with IFNa2. J Mol Biol 289(1):57-67.
20. Piehler J, Schreiber G. 1999b. Mutational and structural analysis of the binding interface between type I interferons and their receptor IFNAR2. J Mol Biol 294(1):223-237.
21. Piehler J, Roisman LC, Schreiber G. 2000. New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J Biol Chem 275(51):40425-40433.
22. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375-386.
23. Roberts RM, Liu L, Alexenko A. 1997. New and atypical families of Type I interferons in mammals: comparative functions, structures, and evolutionary relationships. Prog Nucleic Acid Res Mol Biol 56:287-325.
24. Roisman LC, Piehler J, Trosset JY, Scheraga HA, Schreiber G. 2001. Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and f exible docking. Proc Natl Acad Sci USA 98(23):13231-13236.
25. Schwede T, Kopp J, Guex N, Peitsch MC. 2003. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31(13):3381-3385.
26. Takayanagi H, Sato K, Takaoka A, Taniguchi T. 2005. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208:181-193.
27. Tough DF. 2004. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk Lymphoma 45(2):257-264.
28. Tough DF, Sun S, Zhang X, Sprent J. 1999. Stimulation of naive and memory T cells by cytokines. Immunol Rev 170:39-47.
29. Uzé G, Lutfalla G, Bandu MT, Proudon D. 1992. Behavior of a cloned murine interferon α/β receptor expressed in homospecif c or het-erospecif c background. Proc Natl Acad Sci USA 89(10):4774-4778.
30. Uzé G, Lutfalla G, Gresser I. 1990. Genetic transfer of a functional human interferon a receptor into mouse cells: cloning and expression of its cDNA. Cell 60(2):225-234.
31. Uzé G, Lutfalla G, Mogensen KE. 1995. Alpha and beta interferons and their receptor and their friends and relations. J Interferon Cytokine Res 15(1):3-26.
32. Walter MR. 2004. Structural analysis of IL-10 and type I interferon family members and their complexes with receptor. Adv Protein Chem 68:171-223.
33. Wonderling R, Powell T, Baldwin S, Morales T, Snyder S, Keiser K, Hunter S, Best E, McDermott MJ, Milhausen M. 2002. Cloning, expression, purif cation, and biological activity of f ve feline type I interferons. Vet Immunol Immunopathol 89(1-2):13-27.
34. Yang LM, Xue QH, Sun L, Zhu Y P, Liu WJ. 2007. Cloning and characterization of a novel feline IFN-omega. J Interferon Cytokine Res 27(2):119-127.
35. Zhao W, Lee C, Piganis R, Plumlee C, de Weerd N, Hertzog PJ, Schindler C. 2008. A conserved IFN-α receptor tyrosine motif directs the biological response to type I IFNs. J Immunol 180(8):5483-5489.